VA-ECMO-assisted aspiration thrombectomy in a patient presenting with acute massive PE with absolute contraindications to thrombolytics

Catheter Cardiovasc Interv. 2022 Oct;100(4):705-709. doi: 10.1002/ccd.30329. Epub 2022 Jul 8.

Abstract

Massive pulmonary embolism (PE) is a life-threatening complication of major surgery with a mortality rate up to 50%. First-line therapy for massive PE is systemic thrombolytics, but surgical patients are at high bleeding risk with absolute contraindications. As surgical thrombectomy carries a high burden of morbidity and mortality, endovascular interventions are becoming more common in these clinical scenarios. We report a case of a neurosurgical patient whose postoperative course was complicated by massive PE and subsequent cardiac arrest that required emergent venoarterial extracorporeal membrane oxygenation, followed by aspiration thrombectomy with the Inari FlowTriever Device (Inari Medical). The patient had immediate hemodynamic improvement with eventual recovery to baseline functional status.

Keywords: Inari FlowTriever; VA-ECMO; cardiogenic shock; pulmonary embolism.

Publication types

  • Case Reports

MeSH terms

  • Contraindications
  • Extracorporeal Membrane Oxygenation*
  • Fibrinolytic Agents / adverse effects
  • Humans
  • Pulmonary Embolism* / complications
  • Pulmonary Embolism* / diagnostic imaging
  • Pulmonary Embolism* / therapy
  • Thrombectomy / adverse effects
  • Treatment Outcome

Substances

  • Fibrinolytic Agents